11C-Choline: Clinical Trials

7 trials of 11C-Choline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 2 completed, 1 no longer available. 2 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Unknown 2
Phase 22Completed 1, Unknown 1
Early Phase 11Unknown 1
Phase 11Completed 1

Follow 11C-Choline: new trials by email Literature Review of 11C-Choline trials Research Report on 11C-Choline

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Characterizing LAM With 11C-Choline PET/CT
11C-Choline - Lymphangioleiomyomatosis
Early Phase 1UnknownPeking Union Medical College Hospital502021-11-012021-10-21
[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients
11C-Choline - Prostate Cancer
Not applicableUnknownPeking University Cancer Hospital & Institute202021-01-152024-01-25
PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer
11C-Choline - Prostate Cancer
Not applicableUnknownPeking University Cancer Hospital & Institute502020-10-222024-08-19
Carbon-11 Labeled Sarcosine in Prostate Cancer
11C-sarcosine, 11C-choline - Prostate Cancer
CompletedUniversity of Michigan202015-06-012017-11-09
A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland
11C-Choline - Prostatic Neoplasms
Phase 1 / Phase 2CompletedAHS Cancer Control Alberta212014-03-012021-02-01
Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma
11C-Choline - Hepatocellular Carcinoma
Phase 2UnknownCommissariat A L'energie Atomique302011-06-012011-06-21
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
11C-choline, PET/CT Scan - Prostate Cancer, Recurrent Prostate Cancer
No longer availableMemorial Sloan Kettering Cancer Center2020-06-05

Conditions studied

Prostatic Neoplasms (5)  ·  Carcinoma, Hepatocellular (1)  ·  Lymphangioleiomyomatosis (1)  ·  Neoplasms (1)

Sponsors

Peking University Cancer Hospital & Institute (2)  ·  AHS Cancer Control Alberta (1)  ·  Commissariat A L'energie Atomique (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Peking Union Medical College Hospital (1)  ·  University of Michigan (1)

Countries

China (3)  ·  United States (2)  ·  Canada (1)  ·  France (1)

Top investigators

Fang Li, MD (1)  ·  John Amanie, MD (1)  ·  Morand R Piert, MD (1)

Results publications

PMID 28302759, PMID 34453203

NIH funding

R21CA191052 (1)